PAK1 and Alzheimer disease: In addition, studies have shown that reduction of PAK1 in the cytosolic fraction, occurs due to aberrant activation and translocation of PAK to the membrane cytoskeletal fractions in the AD brain (Ma et al., 2008; Civiero and Greggio, 2018).